CLSDQ — Clearside Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Clearside Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	17.3	30.4	48.3	28.9	20
Net Total Accounts Receivable
Net Total Receivables	—	10	0	0.17	0.507
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.1	42.1	49.4	30.1	21.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.944	0.607	1.87	3.87	3.82
Other Long Term Assets
Total Assets	19.3	42.9	51.3	34	25.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.94	4.64	5.78	6.81	4.79
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.6	4.93	40.7	49.9	64
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	8.76	38	10.6	-15.9	-38.9
Total Liabilities & Shareholders' Equity	19.3	42.9	51.3	34	25.1
Total Common Shares Outstanding